185 related articles for article (PubMed ID: 33943011)
1. Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysis.
Zhu K; Ren P; Yang Y; Wang Y; Xiao W; Zhang H; Yu Z
Thorac Cancer; 2021 Jun; 12(12):1800-1809. PubMed ID: 33943011
[TBL] [Abstract][Full Text] [Related]
2. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
[TBL] [Abstract][Full Text] [Related]
3. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma.
Wang Q; Peng L; Li T; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y; Lang J
Ann Surg Oncol; 2020 May; 27(5):1488-1495. PubMed ID: 31974708
[TBL] [Abstract][Full Text] [Related]
5. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
6. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
Huang W; Wu L; Liu X; Long H; Rong T; Ma G
J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
[TBL] [Abstract][Full Text] [Related]
8. [Outcome of postoperative adjuvant chemotherapy and surgery alone for patients with stage pT1b-3N0M0 squamous cell carcinoma of the thoracic esophagus].
Zhang JZ; Liu JF; Li HY
Zhonghua Wai Ke Za Zhi; 2018 Apr; 56(4):289-293. PubMed ID: 29562415
[No Abstract] [Full Text] [Related]
9. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective study.
Heroor A; Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Sudo T; Matono S; Yamana H; Shirouzu K
Dig Surg; 2003; 20(3):229-35; discussion 236-7. PubMed ID: 12759503
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.
Xu Y; Liu J; Du X; Sun X; Zheng Y; Chen J; Li B; Liu W; Jiang H; Mao W
Radiat Oncol; 2013 May; 8():116. PubMed ID: 23656920
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
Wong AT; Shao M; Rineer J; Lee A; Schwartz D; Schreiber D
Ann Surg; 2017 Jun; 265(6):1146-1151. PubMed ID: 27280504
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
14. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node-positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
Fang S; Zhong J; Mai Z; Li T; Xie X; Fu J
Cancer Med; 2023 Feb; 12(4):4077-4086. PubMed ID: 36134648
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.
Wu SG; Sun JY; Yang LC; Zhou J; Li FY; Li Q; Lin HX; Lin Q; He ZY
Oncotarget; 2015 Nov; 6(34):36911-22. PubMed ID: 26426993
[TBL] [Abstract][Full Text] [Related]
17. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus.
Tabira Y; Okuma T; Kondo K; Kitamura N
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):239-45. PubMed ID: 9918963
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
Yamashita K; Makino T; Yamasaki M; Tanaka K; Hara T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881906
[TBL] [Abstract][Full Text] [Related]
19. [The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
Liu BD; Zhi XY; Xu QS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):586-9. PubMed ID: 15949351
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
